Limitations of the current analysis include the relatively short duration of follow-up (2.1 years) and the relatively small number of MACE, both in the semaglutide group (108/1648 subjects
Its amino acid chains will break, and its conformational structure will unravel
Theres a considerable, unmet need around the treatment of MASH given rising cases and since resmetirom (Rezdiffra) is the only FDA-approved drug for this condition
Every clinic may claim to offer the best results, but those with properly trained professionals and transparency in treatment details stand out
Since coverage policies can change, its best to check with your Medicare provider to confirm the latest eligibility details
While it's natural to compare your hunger experience or weight loss results with others, remember that everyone responds differently to the medication